IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
May 20, 2014 8:05am EDT

Immunovaccine's Novel Immunotherapy Triggers Partial Response and Generates Potent Immune Responses in Ovarian Cancer Clinical Study

Apr 24, 2014 8:05am EDT

Immunovaccine Announces Results of 2014 Annual General Meeting

Apr 08, 2014 8:05am EDT

Immunovaccine's DepoVax(TM) Technology Underpins New Experimental Therapy for Cervical, Head and Neck Cancers

Apr 07, 2014 8:05am EDT

Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AACR Annual Meeting

Apr 03, 2014 8:05am EDT

Immunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual Meeting

Apr 01, 2014 8:05am EDT

Immunovaccine and Pfenex Report Positive Results from Single Dose Anthrax Vaccine Studies

Mar 17, 2014 8:05am EDT

Immunovaccine Announces 2013 Year-End Results

Jan 20, 2014 8:07am EST

Llew Keltner, US Biotech Industry Adviser, Joins Board of Immunovaccine

Jan 20, 2014 8:05am EST

Immunovaccine Grants Stock Options

Jan 09, 2014 8:05am EST

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

RSS
  • Prev
  • 1...
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • ...40
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap